Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Cancer Letters|November 28, 2024
Chemoresistance-motility signature of molecular evolution to chemotherapy in non-muscle-invasive bladder cancer and its clinical implicationsMi-So Jeong, Seung-Woo Baek, Gi-Eun Yang, et al.
Cell Death Discovery|November 7, 2022
Stepwise molecular mechanisms responsible for chemoresistance in bladder cancer cellsJeong-Yeon Mun, Seung-Woo Baek, Mi-So Jeong, et al.
Cancers|December 5, 2020
Visceral Adiposity as a Significant Predictor of Sunitinib-Induced Dose-Limiting Toxicities and Survival in Patients with Metastatic Clear Cell Renal Cell CarcinomaJee Soo Park, Kyo Chul Koo, Doo Yong Chung, et al.
Biomed Research International|March 9, 2017
Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter StudySung Han Kim, Sohee Kim, Byung-Ho Nam, et al.
Plos One|August 27, 2015
Efficacy and Safety of Sorafenib Therapy on Metastatic Renal Cell Carcinoma in Korean Patients: Results from a Retrospective Multicenter StudySung Han Kim, Sohee Kim, Byung-Ho Nam, et al.
BJU International|August 25, 2019
Effects of poloxamer-based thermo-sensitive sol-gel agent on urethral stricture after transurethral resection of the prostate for benign prostatic hyperplasia: a multicentre, single-blinded, randomised controlled trialJae Hoon Chung, Kyu Shik Kim, Jae Duck Choi, et al.
The World Journal of Men'S Health|August 4, 2025
Efficacy and Safety of Mirabegron and Tamsulosin Combination Therapy Compared to Tamsulosin Monotherapy for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Results of a Multicenter, Randomized, Double-Blind, Phase III Clinical TrialSung Chul Kam, Yu Seob Shin, Doo Sang Kim, et al.
Pageof 4